Home » Topics » Regulatory » Patents

Patents
RSS

MT-332: Pharma Mar's novel cytotoxic metabolite

June 28, 1996

Antitumor epidioxymanadic acid described by Pharma Mar

June 28, 1996

More antitumor taxoids

June 28, 1996

LHRH antagonists from TAP Holdings

June 28, 1996

Antitumor taxoids revealed

June 28, 1996

COX-2 inhibitors from Merck Frosst

June 28, 1996

Merck & Co. claims process for synthesizing HIV protease inhibitors

June 28, 1996

Antifungal agents revealed by Merck & Co.

June 28, 1996

Antibacterial agents revealed by Wakunaga

June 28, 1996

Pharmacia & Upjohn reveal antimicrobial phenyloxazolidinones

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...